印度远程医疗指南,2020年有望为全国远程咨询服务的正规化和多样化铺平道路。这个准则是小时的需要,尤其是在当前的冠状病毒大流行期间。所有通信模式(文本,音频,视频,等。)服务提供商和用户之间的内容包括在指南的广义标题中。范围,夹杂物,排除,指南中明确规定了限制。针对特定类型的咨询,对药物进行分组并列出,并通知受限制的药物。该指南尤其有助于减轻立法中的差距,减少不确定性,同时提供切实可行的,安全,以及改善医疗服务提供的成本效益框架;作者讨论了这一新指南的含义以及在全国实施远程咨询服务过程中面临的挑战。
Telemedicine
Guidelines of India, 2020 promises to pave a road map for regularization and diversification of teleconsultation services across the country. This
guideline is the need of the hour, especially during the current coronavirus disease pandemic. All modes of communications (text, audio, video, etc.) between the service provider and user are included in the broad rubric of the
guidelines. Scope, inclusions, exclusions, and restrictions are clearly specified in the
guideline. Medications are grouped and listed for the specific type of consultation, and restricted drugs are notified. This
guideline especially helps mitigate the gaps in legislation and reduces the uncertainty while providing a practical, safe, and cost-effective framework to improve healthcare service delivery in this article; the authors discuss the implications of this new guideline and the challenges during the implementation of teleconsultation services across the country.